These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 308962)

  • 21. Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.
    Rubin AS; MacDonald AB; Coons AH
    J Immunol; 1973 Nov; 111(5):1314-25. PubMed ID: 4583072
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo activity of a nonspecific T cell-replacing factor.
    Kindred B; Bösing-Schneider R; Corley RB
    J Immunol; 1979 Jan; 122(1):350-4. PubMed ID: 153929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.
    Isobe KI; Nakashima I; Nagase F; Kato N; Mizoguchi K; Kawashima K; Lake P
    J Immunol; 1984 Mar; 132(3):1100-5. PubMed ID: 6141204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor.
    Clark-Lewis I; Schrader JW
    J Immunol; 1982 Jan; 128(1):168-74. PubMed ID: 6976369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of nonspecific and specific suppressor T-cell factors in immune responses.
    Pierce CW; Kapp JA
    Agents Actions Suppl; 1980; 7():126-33. PubMed ID: 6166179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA; Piguet PF; Vassalli P
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a low molecular weight helper factor(s) with thymocyte proliferative activity.
    Koopman WJ; Farrar JJ; Oppenheim JJ; Fuller-Bonar J; Dougherty S
    J Immunol; 1977 Jul; 119(1):55-60. PubMed ID: 301539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and physicochemical characterization of murine T cell replacing factor (TRF).
    Takatsu K; Harada N; Hara Y; Takahama Y; Yamada G; Dobashi K; Hamaoka T
    J Immunol; 1985 Jan; 134(1):382-9. PubMed ID: 3871109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of T and B lymphocytes in vitro. IV. Regulatory influence on specific T cell functions by a thymus extract factor.
    Armerding D; Katz DH
    J Immunol; 1975 Apr; 114(4):1248-54. PubMed ID: 1090671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro suppression of spontaneous erythrocyte autoimmune responses with lymphocytes activated with concanavalin A.
    Ramshaw IA; Woodsworth M; Eidinger D
    J Immunol; 1979 Jan; 122(1):265-9. PubMed ID: 368237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
    Jadus MR; Parkman R
    J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of mononuclear cells infiltrating into tumors. IV. Purification and functional characterization of cytotoxic cell-generating factor.
    Murakami T; Uede T; Shijubo N; Torimoto Y; Ide T; Sugimura K; Azuma I; Takai Y; Kikuchi K
    J Immunol; 1988 Dec; 141(12):4235-42. PubMed ID: 3264310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
    Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA
    J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymocyte differentiation activity from the cloned monocyte/macrophage cell line RAW 264.7. Alterations in the expression of immature thymocyte surface antigens.
    McKernan LN; Largen MT
    J Immunol; 1984 Sep; 133(3):1362-70. PubMed ID: 6379047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.